Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. / Kruuse, Christina ; Jacobsen, T B; Lassen, L H; Thomsen, L L; Hasselbalch, S G; Dige-Petersen, H; Olesen, J.

I: Journal of Cerebral Blood Flow and Metabolism, Bind 20, Nr. 9, 09.2000, s. 1372-9.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kruuse, C, Jacobsen, TB, Lassen, LH, Thomsen, LL, Hasselbalch, SG, Dige-Petersen, H & Olesen, J 2000, 'Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects', Journal of Cerebral Blood Flow and Metabolism, bind 20, nr. 9, s. 1372-9. https://doi.org/10.1097/00004647-200009000-00012

APA

Kruuse, C., Jacobsen, T. B., Lassen, L. H., Thomsen, L. L., Hasselbalch, S. G., Dige-Petersen, H., & Olesen, J. (2000). Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. Journal of Cerebral Blood Flow and Metabolism, 20(9), 1372-9. https://doi.org/10.1097/00004647-200009000-00012

Vancouver

Kruuse C, Jacobsen TB, Lassen LH, Thomsen LL, Hasselbalch SG, Dige-Petersen H o.a. Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. Journal of Cerebral Blood Flow and Metabolism. 2000 sep.;20(9):1372-9. https://doi.org/10.1097/00004647-200009000-00012

Author

Kruuse, Christina ; Jacobsen, T B ; Lassen, L H ; Thomsen, L L ; Hasselbalch, S G ; Dige-Petersen, H ; Olesen, J. / Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects. I: Journal of Cerebral Blood Flow and Metabolism. 2000 ; Bind 20, Nr. 9. s. 1372-9.

Bibtex

@article{6538dedc0e07436b9711e3c118532492,
title = "Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects",
abstract = "Dipyridamole is used for secondary prophylaxis in ischemic stroke and as a vasodilator agent in myocardial scintigraphy. An important side effect to administering dipyridamole is headache. The aim of the current study was to investigate the effects of dipyridamole on cerebral blood flow, large artery diameter, and headache induction. Twelve healthy subjects were included in this single-blind placebo-controlled study in which placebo (0.9% NaCl) and dipyridamole 0.142 mg/kg x min were administered intravenously over 4 minutes 1 hour apart. Blood flow velocity in the middle cerebral artery (Vmax) was recorded by transcranial Doppler and regional cerebral blood flow in the middle cerebral artery (rCBFmca) was measured using single photon emission computed tomography and 133Xenon-inhalation. Blood pressure, heart rate, and pCO2 were measured repeatedly. Headache response was scored every 10 minutes on a verbal scale from 0 to 10 (10 = worst). Dipyridamole caused a decrease in pCO2 (P < 0.001). pCO2 corrected rCBFmca was 41.7 +/- 6.9 mL/100 g x min after placebo versus 41.2 +/- 6.9 after dipyridamole (P > or = 0.05). pCO2 corrected Vmca decreased 8.4% +/- 11.7 (P < 0.001) after dipyridamole, indicating a mean 5.6% +/- 6.7 (P = 0.005) relative increase of the arterial diameter. After dipyridamole the median peak headache score was 2 (range 0 to 7) compared with 0 (range 0 to 3) after placebo (P = 0.02). Dilatation of the middle cerebral artery outlasted the headache response. In conclusion, dipyridamole causes a modest pCO2 independent dilatation of the MCA, which is time-linked to the onset, but not to the cessation, of headache.",
keywords = "Adolescent, Adult, Cerebral Arteries, Dipyridamole, Female, Headache, Humans, Infusions, Intravenous, Male, Middle Aged, Vasodilation, Vasodilator Agents",
author = "Christina Kruuse and Jacobsen, {T B} and Lassen, {L H} and Thomsen, {L L} and Hasselbalch, {S G} and H Dige-Petersen and J. Olesen",
year = "2000",
month = sep,
doi = "10.1097/00004647-200009000-00012",
language = "English",
volume = "20",
pages = "1372--9",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "SAGE Publications",
number = "9",

}

RIS

TY - JOUR

T1 - Dipyridamole dilates large cerebral arteries concomitant to headache induction in healthy subjects

AU - Kruuse, Christina

AU - Jacobsen, T B

AU - Lassen, L H

AU - Thomsen, L L

AU - Hasselbalch, S G

AU - Dige-Petersen, H

AU - Olesen, J.

PY - 2000/9

Y1 - 2000/9

N2 - Dipyridamole is used for secondary prophylaxis in ischemic stroke and as a vasodilator agent in myocardial scintigraphy. An important side effect to administering dipyridamole is headache. The aim of the current study was to investigate the effects of dipyridamole on cerebral blood flow, large artery diameter, and headache induction. Twelve healthy subjects were included in this single-blind placebo-controlled study in which placebo (0.9% NaCl) and dipyridamole 0.142 mg/kg x min were administered intravenously over 4 minutes 1 hour apart. Blood flow velocity in the middle cerebral artery (Vmax) was recorded by transcranial Doppler and regional cerebral blood flow in the middle cerebral artery (rCBFmca) was measured using single photon emission computed tomography and 133Xenon-inhalation. Blood pressure, heart rate, and pCO2 were measured repeatedly. Headache response was scored every 10 minutes on a verbal scale from 0 to 10 (10 = worst). Dipyridamole caused a decrease in pCO2 (P < 0.001). pCO2 corrected rCBFmca was 41.7 +/- 6.9 mL/100 g x min after placebo versus 41.2 +/- 6.9 after dipyridamole (P > or = 0.05). pCO2 corrected Vmca decreased 8.4% +/- 11.7 (P < 0.001) after dipyridamole, indicating a mean 5.6% +/- 6.7 (P = 0.005) relative increase of the arterial diameter. After dipyridamole the median peak headache score was 2 (range 0 to 7) compared with 0 (range 0 to 3) after placebo (P = 0.02). Dilatation of the middle cerebral artery outlasted the headache response. In conclusion, dipyridamole causes a modest pCO2 independent dilatation of the MCA, which is time-linked to the onset, but not to the cessation, of headache.

AB - Dipyridamole is used for secondary prophylaxis in ischemic stroke and as a vasodilator agent in myocardial scintigraphy. An important side effect to administering dipyridamole is headache. The aim of the current study was to investigate the effects of dipyridamole on cerebral blood flow, large artery diameter, and headache induction. Twelve healthy subjects were included in this single-blind placebo-controlled study in which placebo (0.9% NaCl) and dipyridamole 0.142 mg/kg x min were administered intravenously over 4 minutes 1 hour apart. Blood flow velocity in the middle cerebral artery (Vmax) was recorded by transcranial Doppler and regional cerebral blood flow in the middle cerebral artery (rCBFmca) was measured using single photon emission computed tomography and 133Xenon-inhalation. Blood pressure, heart rate, and pCO2 were measured repeatedly. Headache response was scored every 10 minutes on a verbal scale from 0 to 10 (10 = worst). Dipyridamole caused a decrease in pCO2 (P < 0.001). pCO2 corrected rCBFmca was 41.7 +/- 6.9 mL/100 g x min after placebo versus 41.2 +/- 6.9 after dipyridamole (P > or = 0.05). pCO2 corrected Vmca decreased 8.4% +/- 11.7 (P < 0.001) after dipyridamole, indicating a mean 5.6% +/- 6.7 (P = 0.005) relative increase of the arterial diameter. After dipyridamole the median peak headache score was 2 (range 0 to 7) compared with 0 (range 0 to 3) after placebo (P = 0.02). Dilatation of the middle cerebral artery outlasted the headache response. In conclusion, dipyridamole causes a modest pCO2 independent dilatation of the MCA, which is time-linked to the onset, but not to the cessation, of headache.

KW - Adolescent

KW - Adult

KW - Cerebral Arteries

KW - Dipyridamole

KW - Female

KW - Headache

KW - Humans

KW - Infusions, Intravenous

KW - Male

KW - Middle Aged

KW - Vasodilation

KW - Vasodilator Agents

U2 - 10.1097/00004647-200009000-00012

DO - 10.1097/00004647-200009000-00012

M3 - Journal article

C2 - 10994859

VL - 20

SP - 1372

EP - 1379

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 9

ER -

ID: 136683446